These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 89511)

  • 41. Replacement hormone therapy in gonadal dysgenesis.
    Dewhurst CJ; de Koos EB; Haines RM
    Br J Obstet Gynaecol; 1975 May; 82(5):412-6. PubMed ID: 1137705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New viewpoints on climacteric in women].
    Kyank H; Dässler CG; Göretzlehner G; Herre HD
    Z Alternsforsch; 1971; 23(4):311-21. PubMed ID: 5123821
    [No Abstract]   [Full Text] [Related]  

  • 43. [Management of patients with hyperplastic and other endometrial changes during the climacteric and menopause].
    Savel'eva GM; Vodianik ND; Zaĭtseva EP
    Akush Ginekol (Mosk); 1973 May; 49(5):7-11. PubMed ID: 4796908
    [No Abstract]   [Full Text] [Related]  

  • 44. Value of cytology for detecting endometrial abnormalities in climacteric women receiving hormone replacement therapy.
    Studd JW; Thom M; Dische F; Driver M; Evans TW; Williams D
    Br Med J; 1979 Mar; 1(6167):846-8. PubMed ID: 435840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology and management of endometrial hyperplasia and carcinoma.
    Fu YS; Gambone JC; Berek JS
    West J Med; 1990 Jul; 153(1):50-61. PubMed ID: 2202159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of hormones in women over forty.
    Stryker JC
    Clin Obstet Gynecol; 1977 Mar; 20(1):155-64. PubMed ID: 189961
    [No Abstract]   [Full Text] [Related]  

  • 47. Endometrial abnormalities occurring in young women on long-term sequential oral contraception.
    Lyon FA; Frisch MJ
    Obstet Gynecol; 1976 Jun; 47(6):639-43. PubMed ID: 934552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Editorial: Oestrogens as a cause of endometrial carcinoma.
    Br Med J; 1976 Apr; 1(6013):791-2. PubMed ID: 1260334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Oestrogens during the menopause and the risk of endometrial carcinoma (author's transl)].
    Lachnit-Fixson U
    Wien Klin Wochenschr; 1979 Feb; 91(4):111-8. PubMed ID: 218369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The climacteric.
    Zussman L
    Proc R Soc Med; 1973 Feb; 66(2):183-5. PubMed ID: 4351701
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapy of juvenile adenomatous hyperplasia of the endometrium by progesterone stimulation].
    Krafft W
    Zentralbl Gynakol; 1989; 111(12):846-8. PubMed ID: 2475003
    [No Abstract]   [Full Text] [Related]  

  • 52. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer.
    Voigt LF; Weiss NS; Chu J; Daling JR; McKnight B; van Belle G
    Lancet; 1991 Aug; 338(8762):274-7. PubMed ID: 1677110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Planning of the treatment of atypical hyperplasia of the endometrium in patients with uterine myoma].
    Tkeshelashvili VT; Bokhman IaV; Vishnevskiĭ AS
    Vopr Onkol; 1984; 30(3):71-6. PubMed ID: 6201002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors.
    Linkov F; Edwards R; Balk J; Yurkovetsky Z; Stadterman B; Lokshin A; Taioli E
    Eur J Cancer; 2008 Aug; 44(12):1632-44. PubMed ID: 18514507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estradiol binding and metabolism in human endometrial hyperplasia and adenocarcinoma.
    Gurpide E; Gusberg SB; Tseng L
    J Steroid Biochem; 1976; 7(11-12):891-6. PubMed ID: 1025366
    [No Abstract]   [Full Text] [Related]  

  • 57. Two successful pregnancies after in vitro fertilization and embryo transfer in a patient with endometrial atypical hyperplasia bordering on adenocarcinoma treated conservatively with high-dose progesterone.
    Piura B
    Gynecol Obstet Invest; 2006; 61(1):21-3. PubMed ID: 16131806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transdermal administration of oestrogen/progestagen hormone replacement therapy.
    Whitehead MI; Fraser D; Schenkel L; Crook D; Stevenson JC
    Lancet; 1990 Feb; 335(8685):310-2. PubMed ID: 1967769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oestrogens and endometrial cancer: a point of view.
    Lauritzen C
    Clin Obstet Gynaecol; 1977 Apr; 4(1):145-67. PubMed ID: 192506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of danazol and tamoxifen on endometrial hyperplasia].
    Soh E
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1612-22. PubMed ID: 2730056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.